Nicholson G C, D'Santos C S, Evans T, Moseley J M, Kemp B E, Michelangeli V P, Martin T J
Department of Medicine, University of Melbourne, Repatriation General Hospital, Heidelberg, Victoria, Australia.
Biochem J. 1988 Mar 15;250(3):877-82. doi: 10.1042/bj2500877.
Receptors for the hypocalcaemic hormone, calcitonin (CT), have been identified in a membrane fraction prepared from term human placentae. Binding of 125I-labelled salmon CT (125I-sCT) to the membranes was time- and temperature-dependent, saturable (Bmax. 58 +/- 11 fmol/mg of protein), of high affinity (Kd 80 +/- 21 pM) and poorly reversible. Species-specific CTs and CT analogues competed for 125I-sCT binding with potencies proportional to their known biological potencies. Various unrelated peptide hormones did not compete, indicating that receptor binding was specific for CT. Photoaffinity labelling using a derivatized biologically active sCT analogue, [Arg11,18,3-nitrophenylazide-Lys14]sCT, identified a receptor component of Mr approximately 85,000, comparable with findings in osteoclasts and other target cells. The presence of CT receptors in the human placenta supports other evidence that CT may have a role in the regulation of placental function.
在足月人胎盘制备的膜组分中已鉴定出降钙素(CT)这种低血钙激素的受体。125I标记的鲑鱼降钙素(125I-sCT)与该膜的结合具有时间和温度依赖性,可饱和(Bmax.为58±11 fmol/mg蛋白质),具有高亲和力(Kd为80±21 pM)且可逆性差。种属特异性CT和CT类似物以与其已知生物学活性成比例的效力竞争125I-sCT结合。各种不相关的肽激素不参与竞争,表明受体结合对CT具有特异性。使用衍生化的生物活性sCT类似物[Arg11,18,3-硝基苯叠氮-Lys14]sCT进行光亲和标记,鉴定出一种分子量约为85,000的受体成分,这与破骨细胞和其他靶细胞中的发现相当。人胎盘中CT受体的存在支持了其他证据,即CT可能在胎盘功能调节中起作用。